Defense World
28 Dec 2025, 10:09 UTC · 38w ago
Verdict
Headline takes no side. We score HQL +0.30 across two claims — moderately bullish.
+0.30moderately bullish
More positive than 57% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish
Short interest in abrdn Life Sciences Investors (HQL) decreased by 34.6% in December to 54,047 shares.
More positive than 42% of claims this week
Approximately 0.2% of HQL shares are currently short sold.
So whatA short interest ratio of 0.2% is negligible and indicates almost no market conviction for a price decline.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
Near neutral — 99% of claims this week are stronger
Which stocks this story touches
More positive than 57% of ticker scores this week
A significant decrease in short interest typically indicates reduced bearish sentiment among investors.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+13.5%
Price agrees with the score
$19.56 vs $17.23 close before publication (Dec 26) · not market-adjusted
HQL chart →
